Online medical consultations: are we heading in the right direction
ONLINE MEDICAL CONSULTATIONS:
ARE WE HEADING IN THE RIGHT DIRECTION?
School of Computing Science, Middlesex University, UK. Abstract
The growth of the Internet over the last 10 years as a medium of information and as a
communication technology has, not unsurprisingly, provided a foundation for the growth of
direct-to-the-public online sales. Amongst the many commercial activities that are now
flourishing in this environment are Internet Pharmacies, providing a variety of products (e.g.
health and beauty products) as well as prescription drugs. Some pharmacies only dispense
drugs with a valid prescription, some provide online consultations for prescribing and
dispensing medicines, and some dispense medications without a prescription. This paper
reports on how technology has facilitated the practice of medicine online, and discusses the
benefits to consumers in terms of access and convenience, together with the problems that
have arisen as a result of remote consultations and lack of professionalism. It discusses legal,
ethical and social issues of concern regarding online medical consultation and prescribing,
and highlights how these present concerns are relevant to looking forward into the future. It
also identifies how advances in technology can impact on online healthcare, both in terms of
providing solutions to present difficulties and in creating further ethical concerns. Finally it
offers some suggestions on how consumers can be safeguarded in light of this evolving
phenomenon. 1. Introduction
The growth of the Internet over the last 10 years as a medium of information and as a
communication technology has, not unsurprisingly, provided a foundation for the growth of
direct-to-the-public online sales. Amongst the many commercial activities that are now
flourishing in this environment are Internet Pharmacies (e-Pharmacies, Cyber Pharmacies),
providing a variety of products (e.g. health and beauty products) as well as prescription drugs.
Some pharmacies only dispense drugs with a valid prescription, some provide online
consultations for prescribing and dispensing medicines, and some dispense medications
without a prescription (Radatz, 2004).
Internet Pharmacies provide various benefits to consumers but also bring many problems for
regulators and consumers (George, 2005). Benefits include: the ease and convenience of 24
hour shopping; increased consumer choice of products; increased consumer information and
information exchange between patient and pharmacist; generally lower costs; privacy; and
availability of alternative treatments. Problems include: uncertainty about the purity and
quality of drugs sold; risks of buying drugs online, for example, related to foreign labels and
use of different drug names in different countries; dispensing prescription drugs without a
prescription; and the issuing of prescriptions through online consultations but without prior
physical examination by a licensed physician. This latter aspect provides the focus of this
The paper will first discuss online consultations, identifying various concerns. It will outline
the regulation of online consultations in the United States (US) and the United Kingdom
(UK), and comment on whether current regulations provide sufficient safeguards for society.
It will then discuss the various legal, social and ethical questions raised by this emerging
practice. The role of Information Technology both in terms of creating such problems but
also possibly facilitating solutions will be examined. Finally, the paper provides some
suggestions on how consumers can be safeguarded in the future. 2. Online Consultations
Many Internet pharmacies provide online consultations as a first step towards selling
prescription medicines online. These consultations usually require that a potential customer
fill out an online questionnaire. A typical online consultation questionnaire (obtained by first
registering then placing an order for drugs at: https://meds4yourhealth.com) may consist of
three parts. The first part asks for personal details such as name, address, contact telephone
numbers, date of birth, height, body weight and gender. The second part of the questionnaire
asks about medical history including: whether a particular drug requested has been used
before; what drugs are currently being taken; a history of allergies and side-effects to certain
medicines; what complaint is the drug requested for; and whether the customer has suffered
from a range of conditions such as heart disease, kidney disease, liver disease, diabetes,
epilepsy, hypertension, asthma, and chronic bowel disorders. The third part asks for payment
details and shipping information.
After the questionnaire is completed, it is then reportedly evaluated by a licensed physician
affiliated to the pharmacy in order to either approve or decline a prescription request. If a
request is approved, a prescription is written by the physician then sent to the pharmacy for
dispensing and shipping of the medication. In addition to the medication, a customer will
received contact information for the pharmacy and information on usage, dosage and
precautions relating to the medication.
Consultations made online, by their very nature, do not involve a physical examination in
person by a licensed physician. Therefore, they may be dangerous both in terms of making a
correct diagnosis and determining drug interactions among other problems (Henney, 2000).
If online questionnaires are not completed truthfully then medications may be prescribed on
false information. Patients also run the risk that a legitimate consulting physician may not be
present to evaluate the online questionnaire. Further, use of general questionnaires may not
provide the necessary information for the determination of a number of important issues such
as whether a particular drug (FTC, 2001): (i) will work for an individual; (ii) is safe to use;
(iii) is more appropriate than another treatment; (iv) may cause adverse reactions if an
individual is taking another medication; or (v) may be harmful due to an underlying medical
condition such as an allergy.
In some cases, doctors who issue online prescriptions (cyberdoctors) are either not licensed to
practice medicine in the consumer’s state/country or are not credible. A US study (BDA,
into the background of cyberdoctors, found that most either: had financial problems; were
sued for malpractice; had their licence revoked; or were recovering from drug addiction.
Another 2003 US study reported that many cyberdoctors recruited by Internet Pharmacies
were previously unemployed, semi-retired or had declining practice incomes (Crawford,
2003). 3. Regulation of Online Consultations
In 2002, the US Federation of State Medical Boards (consisting of members of medical
boards of all US states) published, ‘Model Guidelines for the appropriate use of the Internet
in Medical Practice’
(FSMB, 2002). Two of the guidelines specifically addressed the issue of
remote prescription practices, referring to “documented patient evaluation” (including a
patient history and physical evaluation) and stating that “Issuing a prescription based solely
on an online questionnaire or consultation does not constitute an acceptable standard of care”
(FSMB, 2002). Further, guidelines issued by the American Medical Association in 2003
(regarding the prescribing of medicines to patients via the Internet) state that a physician who
prescribes medications via the internet must establish or have an established a valid patient-
physician relationship (AMA, 2003). This includes among other things: obtaining a reliable
medical history and performing a physical examination of the patient; having sufficient
dialogue with the patient regarding treatment options, and risks and benefits of the treatment;
and having follow-ups with the patient where appropriate.
In 2004 the General Medical Council (GMC) in the United Kingdom issued new practice
guidelines which have similar regulatory goals to the US position but some noticeable
differences (GMC, 2004). The GMC details conditions to be met for remote prescribing in
situations where a practitioner is either: continuing to care for a patient; deputising for another
doctor responsible for the patient; or has prior knowledge and understanding of the patient’s
condition and medical history and has access to the patient’s medical records. In the absence
of these situations, however, the GMC does not expressly forbid remote prescribing but gives
additional conditions to be satisfied if remote prescribing is to be used. These additional
conditions include (GMC, 2004): having appropriate dialogue with the patient to assess the
patient’s current medical conditions and any medications being taken; being able to
adequately assess the patient’s condition and the cause of such condition; being able to justify
medicines/treatment proposed and discuss alternative treatments with the patient; being able
to assess any contra-indication effects of medicines/treatments proposed; and keeping a
record of all medicines prescribed. 4. Legal, Ethical and Social Concerns
In both the US and UK, doctors have been prosecuted for using online consultations to
prescribe drugs. In January 2002, Dr Richard Franklin was found guilty of serious
professional misconduct by the GMC after prescribing drugs online (BBC, 2004). Patients
were required to fill out an online questionnaire which was then reviewed by Dr Franklin and
used to prescribe drugs. The GMC stated that the questionnaire was closed and did not allow
for a dialogue between doctor and patient. Also, that Dr Franklin did not carry out an
adequate assessment of his patients’ conditions, and therefore did not act in the best interests
of his patients (BBC, 2004). In August 2004, Dr Shreelal Shindore, of Florida (US) was
forced to relinquish his medical license after “prescribing a Schedule IV controlled substance
to a patient who completed an Internet questionnaire without conducting a physical
examination, obtaining a complete history, without making a diagnosis and without
establishing a treatment plan” (NYSBPM, 2004).
4.1 Legal Issues
The writing of prescriptions via online consultation may raise important legal issues,
especially related to confidentiality and civil liability for medical malpractice should
something go wrong (Kahan et al, 2000). Confidentiality issues may arise because
information given for online consultations may be prone to be seen by people other than the
consulting doctor, unless strict security and protocols are in place (Kahan et al, 2000). This
has important implications within the European Union/United Kingdom (EU/UK) with regard
to obligations under data protection law. In the EU/UK medical data is treated as ‘sensitive
personal data’ and acknowledged as a special category (amongst others such as ethnic origin,
religious belief) which requires a higher level of protection compared to ordinary personal
data. Civil liability issues may arise since liability for malpractice may not be clearly
established where an online prescription is issued (Kahan et al, 2000). This is because
whereas in a traditional doctor-patient relationship a clear duty of care exists, it is debatable
whether a doctor who prescribes medication online (without any direct verbal or physical
contact with a patient), forms a doctor-patient relationship and therefore attracts the same duty
The Internet crosses geographic and state boundaries and hence creates a global market for
commerce. It is thus relatively easy for a medical practitioner to be located within one
jurisdiction and to administer an online consultation to a patient located in a different
jurisdiction, without being licensed to practice medicine in either of the jurisdictions. The
practice of medicine within any jurisdiction without an appropriate licence is a criminal
offence, since it places citizens at a serious risk. It may, however, be difficult to successfully
prosecute a medical practitioner located in a jurisdiction different to that of the patient. This is
especially true where the appropriate legal agreements between jurisdictions (especially
countries) are not present, or where it is prohibitively expensive to do so. 4.2 Ethical Issues
The ethical issues are closely related to the legal concerns expressed above. In the cases
reported in the previous section, national legislation serves to protect patients and uphold the
established ethical practices of the medical profession. The foundation for the ethical
principles of the medical profession (in the western world) is the Hippocratic Oath (Nova,
2001a). The principles enshrined in this code, as with many ethical codes, are high level
principles that take into account the power imbalance between the expert and the ill-informed.
Key principles are the prevention of harm and injustice, and maintaining patient
It is hard to see how the questionnaire approach to medical consultations can adequately
address the prevention of harm, and the imbalance between expert and non-expert. The
dialogue between doctor and patient that is traditionally conducted face-to-face is an
important aspect of a doctor’s practice especially with regard to his duty to prevent harm (as
far as is reasonably possible). In this context the doctor makes an assessment of the condition
that is presented at that time, based on a number of factors that give an overall picture of the
health of the patient – such things as skin tone and texture, condition of eyes, tongue, reaction
to touch, and many others. This rich picture is built from experience and comes largely from
tacit knowledge. Doctors in this familiar setting are also in a position to share information
with the patient, and are in a much better position to establish that the patient understands
what they are saying – whether it be information about the condition, or, vitally, information
concerning drug use. Thus some measure of informed consent (an underlying principle of an
ethical action) can be achieved. When completing an online questionnaire, the level of
language competence and understanding within the medical context (discussed later) has
serious implications for this generally held principle of informed consent – how informed is
the consumer under such circumstances?
We have questioned the legal status of patient confidentiality, and raise it again as an ethical
issue. Doctors who prescribe drugs online could argue that the precautions they take to ensure
confidentiality are at least as good as the measures used in more traditional settings. We
cannot say that patient files are totally secure in either the off-line or online environment.
However, it would be safe to say that there is an increased opportunity to gain access to
confidential material online, with much less risk of being caught, even where the best security
measures are in place. If security measures are not in place, then patient confidentiality is not
provided for. What is more, if access to this information is inadequately protected online, the
extent of the spread of this information is potentially on a ‘massive’ scale. Once leaked it
would be impossible to contain, or conduct any damage limitation. Whilst the vulnerability of
personal data is a general concern in online activities, and not exclusive to online medical
practices, personal medical information is highly sensitive and warrants special care (under
data protection legislation). We would argue that because this information is valuable to third
parties (pharmaceutical and insurance companies, for instance) it is especially at risk online.
Finally, the practice of prescribing drugs online favours the assumption that drugs are the best
solution to the problem, and this may not necessarily be the case. There is already a
questionable cultural trend in the US and the UK to use drugs as the first line of attack for
many conditions. Patients visit their doctor and expect a solution to their condition in the form
of pill, and it is often easier for doctors under pressure to prescribe drugs than investigate
other possible causes (such as living conditions or life style for example). McCoy (2005)
refers to this trend as the “over-biomedicalisation of healthcare”, that is, the lack of attention
to life context, and reduction of illness to something that can be solved by prescription. This
trend, according to McCoy, is as a result of pressure exerted by pharmaceutical companies,
directly and indirectly through advertising (McCoy, 2005).
It may be worth noting at this point the following extract from the modern version of the
“I will remember that there is art to medicine as well as science, and that warmth, sympathy,
and understanding may outweigh the surgeon’s knife or the chemist’s drug” (Nova, 2001b), 4.3 Social Issues
The two cases reported above raise a number of social issues. In general terms, buying
prescription drugs remotely encourages a culture of independence from recognised
institutional practices and undermines the ethos of risk associated with such drugs. Drugs that
are designated prescription-only are considered to carry risk under certain conditions - if they
were not they would be available for anyone to buy. The issuing of a prescription implies that
an expert has taken the medical characteristics of the patient into account, the risks and
benefits of prescribing the drug, and has recommended a course of treatment based on those
factors. By offering an “easy” route to buying drugs, it could be argued that the practitioner
prescribing online is complicit in undermining the best practice advice of recognised
There is also a wider social implication to bypassing the traditional route
and using an e-commerce model, and this is the issue of patient protection. One of the purposes of a professional medical body (or other professional body) is to provide protection for those seeking expertise, that is, those who are less expert and therefore vulnerable in their lack of knowledge (Duquenoy, 2003). The case above, of Dr. Franklin, illustrates this aspect where the GMC stated that Dr. Franklin did not act in the best interests of his patients. Whilst the law has taken action in this particular case it may become increasingly difficult to monitor the activities of doctors practicing in this way – and in particular in areas where either no medical body exists, or where a medical body does not have the weight of established professional bodies such as the GMC in the UK, and FSMB in the US. At the individual level, the online questionnaire takes no account of the level of literacy of the patient – either in terms of understanding terminology used in the context of health, competence in the language used in the questionnaire, or specific cultural interpretations. When completing an online medical questionnaire, a respondent may not completely understand a question and may “guess” an answer, or may misinterpret a question and give an invalid answer. These issues are extremely relevant where drugs are bought and sold in a global market-place, where language competence and understanding of medical terminology can vary. A lack of understanding of the medical context, and particularly familiar medical culture, could have drastic effects. To illustrate our point, the following questions (below) are taken from an actual online consultation questionnaire at https://meds4yourhealth.com. Notice that some of the questions are expressed in medical terms which are not immediately obvious to a non-medical person. Do you suffer from or currently have Cardiac or (ischemic) heart disease?
Do you suffer from or currently have Transient ischemic attack(s) (TIA’s)?
Do you suffer from or currently have Diabetes?
Do you suffer from or currently have Epilepsy?
Do you suffer from or currently have Hypertension (exceeds either value of 80/120 mm Hg)? Do you use MAO-inhibitors like phenelzine or moclobemide? Do you use NSAID’s (nonsteroidal anti-inflammatory drug - f.i. salicylates, diclofenac, naproxen)? While terms such as ‘Diabetes’ and ‘Epilepsy’ are familiar to most people, we suggest that it is doubtful that someone would know whether they had a “transient ischemic attack” or whether they suffered from Hypertension that “exceeds either value of 80/120 mm Hg”. Also medical terms such as ‘MAO-inhibitors’ and ‘NSAID’ are not commonly used amongst the general population. It is also interesting that the following disclaimer is included in the questionnaire (note: this is only the first of a total of four clauses): I declare without any restriction: (a) that I have read the terms and conditions and the disclaimer on this website and agree with their content and applicability
This approach is surely very different from the type of doctor/patient interaction that takes
place in a surgery – patients in the traditional role are not asked to agree to any “disclaimer”.
Another important issue concerns the authenticity of the patient request – does this person
really have the symptoms the drug will alleviate, are they buying for someone else, or buying
to sell on to others? Also it is possible for a minor (under 18 years old) to buy drugs. In a
2003 briefing to the US Congress, an investigator reported that his 9 year old daughter
successfully ordered a prescription weight-loss drug on the US Drug Enforcement
Administration (DEA) controlled substance list (Lueck, 2003). In addition, his 13 year old
son ordered and received Prozac, a drug on the US Food and Drug Administration’s (FDA)
Import Alert list (Lueck, 2003).
Finally there is the issue of follow-up treatment once a medication has been prescribed. In the
case of Dr. Shindore it was reported that no treatment plan was established. One wonders
whether some purchasers are choosing to get the drugs online because they prefer a one-off
interaction, and whether they appreciate the potentially harmful implications of such a one-off
deal. Even if advice is given as to the period of time the drug should be taken, when a
reassessment is due, what contra-indications may appear, the purchaser may not (a) take any
notice, or (b) not fully understand. Furthermore, the purchaser of online drugs may find it
difficult to effectively communicate concerns, developments or changes in symptoms, since
he/she cannot be physically assessed by a medical practitioner. 5. Summary and Conclusion
In this paper we have provided an overview of the practice of selling drugs online,
highlighting some of the benefits and problems associated with this phenomenon. We then
focused on the use of online consultations to facilitate the sale of prescription drugs, and
outlined the related regulatory frameworks which exist in the US and UK. Further, we
discussed some legal, ethical and social issues of concern which may arise with regard to the
use of online consultations.
Some legal issues of concern discussed were: confidentiality of patent information especially
in light of EU/UK data protection law; civil liability for medical malpractice, in light of the
extent to which a duty of care in an online consultation is comparable to that which exists in
the traditional doctor-patient relationship; whether a medical practitioner is licensed to
practice medicine within the jurisdiction where he/she is located, and also in the jurisdiction
where the patient is located (if different).
In our discussion of ethical issues we questioned the reasons for buying online. One reason
may be that someone may want large quantities of a particular drug – much easier to get
online by visiting different sites. The purchaser may be contemplating suicide, or may be
planning to sell the drugs on at a profit and bypassing any regulations that protect the user.
Other issues were patient confidentiality; informed consent; and finally, the implicit
assumption that prescribing drugs is the most appropriate form of treatment for the patient.
With regard to social issues, the subtle but clear move from a face-to-face interaction towards
a simple “form-filling” exercise is likely to encourage a casual and less informed approach to
drugs that carry some risk, and has an added impact in undermining the status of the medical
profession. We are also concerned about the level of understanding on the part of the
purchaser, the verification of authenticity of the patient request and the potential for a lack of
continuous monitoring and advice concerning the patient’s medical condition. Finally we
suggest that with online consultations, the risks to the consumer are greater and the level of protection less, compared to the traditional off-line medical consultation. All of the present concerns discussed above are relevant to future developments. Technology is moving on, and the Internet has brought with it an irrevocable cultural change. Opportunities have arisen that allow consumers more choice in how they purchase goods, and from whom. With developments in mobile technologies and increased access to the Internet, the preponderance and use of online pharmacies is likely to grow. Many of the concerns we have raised will continue to be relevant. These include: at the medical level: issues related to disassociation of remedy from cause, disassociation from personal expert advice and the consequent clinician/patient relationship that is formed over time (which includes knowledge of the patient’s personality, medical history, and social context) at the purchaser level: language competence and understanding in multi-cultural states, and cross-national transactions. at the technological level: issues of confidentiality and security of personal data at the legal level: issues of confidentiality, data protection, civil liability for malpractice, and enforcement of inter-jurisdictional offences. Advances in technology can impact on the provision of online healthcare, both in terms of providing solutions to present difficulties and in creating further legal, ethical and social concerns. Technology can provide solutions by aiding doctors in making better diagnoses at a distance, for example: use of video for examining patients and use of medical instruments that can be used to carry out various medical tests on a patient. Technology can also provide better security for information, aid regulatory bodies and enforcement authorities in their duties and help promote public awareness of important issues. Unfortunately technologies are also likely to be abused or subject to malfunction or failure. This further raises: legal concerns such as where legal liability for failure of a technology lies; ethical concerns such as the potential for misuse of a new technology; and social concerns such as how a technology impacts on current norms and practices. The discussions above imply a need for continuing regulatory and ethical scrutiny of the evolving social phenomenon of online medical practice. Present regulatory frameworks and ethical codes of conduct may not adequately address the future scenarios that could develop. Although legitimate Internet pharmacies appear to adhere to the provisions of the existing regulatory frameworks, as discussed earlier, the problem really lies with rogue pharmacies that are driven by commercial profits and operate without regard to either regulatory or ethical guidance. Having seen the rather futile efforts to dissuade Internet users from utilising its resources (for example, by the music industry to prevent the sharing of music files), we argue that the medical profession will need to consider how they can best adapt to Internet practices using technology, policy and legislation, and consumer education, to adequately protect the patient. Any adaptation, however, should not lower the established medical standards and hence put patients at potential risk. The global risk to the health and well-being of everyone dictate that ethical codes of conduct and regulatory frameworks need to be constantly reviewed and updated not only to address online medical practitioners, but also other players that facilitate this commercial activity. Thus appropriate ethical guidance and regulation should be aimed at technologists, delivery specialists and credit card companies among others in the stream of
online medical commerce. The need to protect consumers from the potential harmful
consequences of online consultations should be a core principle, guiding the conduct of all
commercial entities. We argue, finally, that perhaps the only way forward into the future is for
more international consensus, cooperation and agreement to establish global ethical and
regulatory standards for online medical practice, to safeguard us all. References
AMA (2003). H-120.949 Guidance for Physicians on Internet Prescribing.
BBC (2004). Viagra web doctor suspended, BBC News, 10th January 2004.
BDA (2003). Beau Dietl Conducts Investigation Into Internet Prescription Drug Scams.
October 2003. accessed 18.06.2005
Crawford, S (2003). Internet Pharmacy: Issues of Access, Quality, Costs and Regulation,
Journal of Medical Systems, Vol.27, No.1, Feb 2003.
Duquenoy, P. (2003). “Models for Internet Ethics” in Risks and Challenges of the Network
Society, Proceedings of the Second IFIP 9.2., 9.6/11.7 Summer School, Karlstad, Sweden.
Penny Duquenoy, Simone Fischer Hübner, Jan Holvast and Albin Zuccato (Eds.) Pp.51-60.
FSMB (2002). Model Guidelines for the Appropriate use of the Internet in Medical Practice.
lines.htm accessed 18.06.2005
FTC (2001). Offers to Treat Biological Threats: What You Need to Know. Federal Trade
Commission, Consumer Alert. October, 2001.
George, C. (2005). Internet Pharmacies may not be good for your health. IFIP WG 9.2
Conference on Landscapes of ICT and Social Accountability. June 27-29, 2005. University of
Turku, Turku, Finland.
GMC (2004) http://www.gmc-uk.org/standards/prescribing_medicines_faq.htm#9
Henny, J (2000). Online Pharmacies – Maintaining the Safety Net, Medscape Pharmacists
Kahan, S, Seftel, A and Resnick, M.(2000). Sildenafil and the Internet, The Journal of
Urology. Vol. 163, 919-923, March 2000.
Lueck, S (2003). Drug Industry Enlists An Ex-Cop Lobbyist.
The Wall Street Journal.
October 22, 2003.
McCoy, D. (2005) “Strong Medicine”, RSA Journal, June 2005. Pp48-53.
NYSBPM (2004). Report on professional medical misconduct. New York State Board for Professional Misconduct. http://w3.health.state.ny.us/opmc/factions.nsf/0/7d54e09e72517b5485256f50006d5f06/$FILE/lc112252.pdf accessed 18.06.2005 Nova (2001a). Hippocratic Oath - Classical Version accessed 18.06.2005Nova (2001b). Hippocratic Oath - Modern Version http://www.pbs.org/wgbh/nova/doctors/oath_modern.html accessed 18.06.2005Radatz, C. (2004). Internet Pharmacies, Wisconson Briefs, Brief 04-5, March 2004. http://www.legis.state.wi.us/lrb/pubs/wb/04wb5.pdf accessed 18.06.2005
The CPN liaison service To provide a seamless mental health cases who, however, continue to be referred to service across the primary / secondary care CMHTs by GPs who feel that they do not have thenecessary expertise. Thus, there is a risk that some interface, it is necessary to look at the patients might find that neither primary nor needs of modern primary care and secondary care
SENIOR NUGGET — NOVEMBER 2013 GOOD HEALTH ISN’T A LONG SHOT - GET VACCINATED SHINGLES— known as herpes zoster, is caused by vermicelli-zoster virus (same virus that causes chickenpox). Once you have had chickenpox, the vermicelli-zoster virus remains in your body’s nerve tissues. It can be dormant or reactivate later in life. This causes shingles. If you are over 50 and have h